Albumin Market size was over USD 5.68 billion in 2024 and is poised to reach USD 12.51 billion by the end of 2037, growing at around 6.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of albumin is assessed at USD 5.97 billion. The rising cases of liver diseases and infection have increased the demand for albumin, thus, driving market growth. The worldwide incidence of cirrhosis from autopsy results ranges from 4.5% to 9.5% of the population as a whole. It is estimated that in the next few years, more than fifty million adults worldwide will be afflicted with chronic liver disease. In the liver diseases, such as Ascites, albumin is used as a component for removing excess fluid from the abdomen. It helps prevent complications such as renal dysfunction and hypovolemia by maintaining plasma volume.
Furthermore, the rising discovery of new albumins is expected to augment the market growth. In April 2022, the article Impact of Serum Albumin Levels on COVID-19 Mortality implied that during admission if a COVID patient is injected with low levels of albumin serum. It can identify the patient who is at high risk of pneumonia and respiratory failure.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.4% |
|
Base Year Market Size (2024) |
USD 5.68 billion |
|
Forecast Year Market Size (2037) |
USD 12.51 billion |
|
Regional Scope |
|
Type (Recombinant Albumin, Human Serum Albumin, Bovine Albumin)
The human serum albumin segment is estimated to hold over 55% share of the albumin market in the year 2037. The segment growth is due to a rise in the number of new drug development followed by higher expenditure in the R&D in the pharmaceutical industry. Within the next five years, through 2026, more than three hundred new medications are scheduled to be introduced onto the market. This is a considerable rise above the preceding decade’s average. Moreover, globally around USD 196 billion is expected to be invested in the research of new drugs. Human serum albumin is often used in the formulation of drugs to improve their stability, solubility, and bioavailability. Human serum albumin increases drug solubility, especially for poorly water-soluble compounds. Moreover, it also acts as a stabilizer, preventing degradation or aggregation of drug molecules.
Application (Drug Formulation & Vaccines, Therapeutics, Research)
The therapeutics segment is expected to accumulate a notable revenue share of around 45% in the year 2037. Rising cases of severe burns and other traumas will drive the growth of the segment. Severe burns lead to extensive fluid loss and dehydration. Albumin is used as a plasma expander to restore and maintain intravascular volumes, and it is also used for maintaining oncotic pressure restoration.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Grade |
|
|
Application |
|
North American Market Forecast
The albumin market in North America is projected to be the largest with a share of about 35% by the end of 2037. The growth of the market can be attributed majorly to the increasing production of immunoglobins and this is further driven by a rise in the number of HIV patients. Moreover, in 2021, Pfizer Inc. received the approval of the U.S. Food and Drug Administration (FDA) for the application of (sBLA) for PANZYGA, it is an intravenous immunoglobulin for treating the patient suffering from chronic inflammatory demyelinating polyneuropathy (CIDP).
APAC Market Forecast
The Asia Pacific albumin market is estimated to be the second largest, registering a share of about 28% by the end of 2037. The higher number of people suffering from heart issues will boost the market growth in the region. Albumin’s ability to exert oncotic pressure, which is important during cardiac surgery to prevent edema and ensure proper perfusion. Over the last several decades, projections of the overall incidence of coronary heart disease in India have dramatically increased from around 1.6% to nearly 7.4% in rural populations and from 1% to 13.2% in urban populations.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?